 | |
 | |
| Combination of | |
|---|---|
| Ampicillin | β-lactam antibiotic (penicillin)[1] |
| Flucloxacillin | β-lactam antibiotic (penicillin)[1] |
| Clinical data | |
| Routes of administration | Oral, intravenous, intramuscular[2] |
| ATC code | |
| Identifiers | |
| CAS Number | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| (verify) | |
Ampicillin/flucloxacillin (INNs) also known as co-fluampicil (BAN), and sold under the tradename Magnapen, is a combination drug of the two β-lactam antibiotics, ampicillin and flucloxacillin, both in equal amounts, available in a capsule and as a liquid, both taken by mouth, and as a formulation which can be given by injection into muscle or vein.[2][3]
It is used to treat infections before the laboratory results confirm the causative organism.[4] Side effects include stomach or bowel upsets.[2] It should not be taken by people allergic to penicillin.[2][5]
- ^ a b Tidwell TT (2017). "Beta-Lactams from ketene- Imine Cycloadditins: An Update". In Banik BK (ed.). Beta-Lactams: Novel Synthetic Pathways and Applications. Edinburg, Texas: Springer. p. 106. ISBN 978-3-319-55621-5.
- ^ a b c d "5. Infection". British National Formulary (BNF) (80 ed.). BMJ Group and the Pharmaceutical Press. September 2020 – March 2021. p. 582. ISBN 978-0-85711-369-6.
- ^ "Magnapen". www.mims.co.uk. Archived from the original on 16 January 2021. Retrieved 18 December 2020.
- ^ Cite error: The named reference
Drug.comwas invoked but never defined (see the help page). - ^ "Co-fluampicil for bacterial infections. Side effects and dosage". patient.info. Archived from the original on 15 January 2021. Retrieved 18 December 2020.